Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Net Income From Continuing Operations : ₹28.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Vaidyane Ayurved Laboratories's net income from continuing operations for the six months ended in Mar. 2024 was ₹13.0 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₹28.6 Mil.

Vaidyane Ayurved Laboratories Net Income From Continuing Operations Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Net Income From Continuing Operations Chart

Vaidyane Ayurved Laboratories Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-4.47

16.10

47.64

64.32

28.65

Vaidyane Ayurved Laboratories Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial				34.37	37.28	27.04	15.69	12.95

Vaidyane Ayurved Laboratories Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹28.6 Mil.

Vaidyane Ayurved Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604

Website

https://www.madhavbaug.org

Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines